Atlas Trials

Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients

Clinical trial NCT01439009 · COMPLETED

Trial details

NCT number
NCT01439009
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure
Start date
2011-09-01
Primary completion
2014-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.